CHJ.66252
Human Collagen Type IV
--
--
Ordering
Available Variants100 μg
CHJ.66252-100μg
Price
€257.60
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
100 μg | CHJ.66252-100μg | €257.60 |
from human placenta, liquid, High Performance
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| CAS Number | 9007-34-5 |
|---|---|
| UNSPSC Code | 41106305 |
| NACRES | NA.51 |
| EC Number | 232-697-4 |
| MDL number | MFCD00130825 |
| Form | solution |
| Biological source | human placenta |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 1 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
Human Collagen Type IV, with a CAS number of 9007-34-5, is a crucial component of the basement membrane, a thin, fibrous structure that separates and supports epithelial and endothelial cells. This collagen type is characterized by its unique network-like structure, which provides mechanical strength and stability to the basement membrane. Human Collagen Type IV is composed of alpha chains, specifically alpha 1 to alpha 6, which assemble to form a triple-helical structure. It plays a vital role in maintaining tissue integrity, regulating cell behavior, and facilitating cell-matrix interactions. The study of Human Collagen Type IV has significant implications for understanding various diseases, including cancer, kidney disease, and muscular dystrophy, where basement membrane dysfunction is often observed. Further research on this collagen type may lead to the development of novel therapeutic strategies for these diseases.
